LSTA - Lisata Therapeutics

-

$undefined

N/A

(N/A)

Lisata Therapeutics NasdaqCM:LSTA Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Location: 110 Allen Road, Basking Ridge, NJ, 07920, United States | Website: https://www.lisata.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-2.954M

Cash

25.83M

Avg Qtr Burn

-4.433M

Short % of Float

0.33%

Insider Ownership

20.18%

Institutional Own.

9.11%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
LSTA12 (HONEDRA®) Details
Critical limb ischemia

Phase 3

Update

Certepetide (LSTA1) Details
Pancreatic cancer, Cancer

Phase 2b

Data readout

LSTA1 + temozolomide Details
Cancer, Glioblastoma, Glioma

Phase 2a

Data readout

LSTA1 + Standard of care Details
Cancer, Solid tumor/s, Cholangiocarcinoma

Phase 2a

Data readout

Phase 1/2

Data readout

LSTA1 + FOLFIRINOX (neoadjuvant) + panitumumab Details
Pancreatic cancer, Cancer, Colorectal cancer

Phase 1/2

Data readout

Phase 1/2

Data readout

LSTA1 + nivolumab/FOLFIRINOX, Details
Cancer, Gastroesophageal adenocarcinomas

Phase 1/2

Update

Phase 1/2

Initiation

XOWNA (CLBS16) Details
Coronary Microvascular Dysfunction

Failed

Discontinued

Failed

Discontinued

LSTA201 (CLBS201) Details
Chronic kidney disease

Failed

Discontinued